Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Merck describes factor Xa inhibitors and their use in thromboembolic conditions

May 10, 2000

Pamiteplase, a novel t-PA, offers possibility of single bolus injection

May 8, 2000

Selective thrombin inhibitors described in recent patent by Merck researchers

May 4, 2000

In vivo pharmacological profile of antiplatelet agent CS-747

May 3, 2000

New gpIIb/IIIa inhibitor for i.v. administration with sustained pharmacodynamic effects

May 2, 2000

Preliminary clinical data confirm positive effect of oral heparin dosage form

April 26, 2000

Aventis prepares new selective factor VIIa inhibitors

April 24, 2000

Health Canada approves Aggrenox for prevention of recurrent stroke

April 20, 2000

PEG-hirudin superior to unfractionated heparin for short-term reduction of silent ischemia

April 20, 2000

Delivery of factor VIII gene using lentiviral vectors reported by Cell Genesys

April 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...